Home > Products > Chemicals > Pharmaceutical Chemicals > Immune Function Agents (202)
Language Options more
Check out all Product Listings for Sirolimus
Related Searches: Sirolimus

Sirolimus

Place of Origin: China (Mainland)
Brand Name: holypharm
CAS No.: 53123-88-9
Payment Terms: L/C,T/T
Click to send an inquiry

Supplier Details

Zhejiang Holypharm Biotech Co., Ltd.

[ Zhejiang, China (Mainland) ]
Gold Supplier [ 1st Year] Verified Supplier
  • Business Type:Manufacturer, Trading Company, Distributor/Wholesaler
  • Product/Services:Pharmaceutical raw materials,pharmaceutical intermediate,agrochemical ...
  • Online Showroom: 855 products
similar products from this supplier
View this Supplier's Website >>
  • Product Details
  • Company Profile
  • Place of Origin: China (Mainland)
  • Brand Name: holypharm
  • CAS No.: 53123-88-9

Sirolimus

CAS NO.:  53123-88-9

Sirolimus , also known as rapamycin, is an immunosuppressant drug used to prevent rejection in organ transplantation; it is especially useful in kidney transplants. A macrolide, sirolimus was first discovered as a product of the bacterium Streptomyces hygroscopicus in a soil sample from Easter Island an island also known as "Rapa Nui", hence the name.
Sirolimus was  potent immunosuppressive and antiproliferative properties.
Molecular Formula : C33H31NO2

Formula Weight : 473.6

Send your message to this supplier

Sirolimus
Sirolimus
Sirolimus
Sirolimus CAS NO.: 53123-88-9
Sirolimus CAS 53123-88-9
Sirolimus Cas:53123-88-9 Immune function agents Sirolimus products tested by the proton NMR spectrum
Min. Order: 1 Gram
Sirolimus
Sirolimus Cas:53123-88-9 Immune Function Agents Sirolimus products tested by the proton NMR spectrum
Min. Order: 1 Gram
Sirolimus
Sirolimus Quality assured reseanable price
Rapamycin (Sirolimus)
Rapamycin (Sirolimus) Cas:53123-88-9 Our products tested by the proton NMR spectrum
Rapamycin
Rapamycin CAS: 53123-88-9

Let supplier know exactly what you're looking for Post Buying Leads Now!

View More Related Items

Email this page Bookmark this page Print this Page